Social support key to successful early HCV treatment

Optimising social support for patients embarking on treatment of hepatitis C (HCV) is a key to good patient outcomes, researchers have found. Latest research from the Australian Trial of Acute Hepatitis C (ATAHC) study published in PLOS One found that social stability influences treatment uptake and virological outcome, and may continue to do so even ...

Already a member?

Login to keep reading.

© 2021 the limbic